Features of duodenogastric refl ux in gastric ulcer
https://doi.org/10.31146/1682-8658-ecg-200-4-65-70
Abstract
At the moment the approach to the treatment of gastric ulcer (GU) does not depend on the location of the ulcer in one or another part of the stomach. We compared gastric secretion, duodenogastric refl ux characteristics and Helicobacter pylori infection in patients with “high” and “low” gastric ulcers. 96 patients with recurrent GU were examined; 71.9% of men and 28.1% of women. In 58 patients, a “high” localization of the ulcer was detected, and in 38 patients, a “low” (pyloroantral) ulcer was diagnosed. All patients underwent esophagogastroduodenoscopy and daily intragastric pH-metry prior to the appointment of antisecretory therapy. The data were compared with the results of healthy volunteers. The frequency of detection of Helicobacter pylori infection was comparable with diff erent localization of gastric ulcer. We were able to show that with “high” ulcers, intragastric acidity in terms of fundal and antral pH and its circadian dynamics were comparable to healthy people. With “high” ulcers, the frequency of duodenogastric refl ux was close to normal, but their total duration was higher due to an increase in the proportion of prolonged and high refl ux. With “low” gastric ulcers, we noted a very high and monotonous acidity in the body and antrum of the stomach, combined with a decrease in the frequency and duration of duodenogastric refl ux. Consequently, both “high” and “low” stomach ulcers suggest the appointment of antisecretory drugs. At the same time, the detection of “high” stomach ulcers associated with excessive duodenogastric refl ux can be considered as a basis for prescribing bismuth tricalium dicitrate, including as part of the Helicobacter pylori eradication therapy, or ursodeoxycholic acid.
About the Author
I. Yu. Kolesnikova
Tver State Medical University
Russian Federation
Russian Federation
Irina Yu. Kolesnikova, MD, PhD, Vice- Rector for Academic and Educational Work; professor of the department of hospital therapy and occupational diseases
Scopus Author ID: 7005390215, Researcher ID: ABG-5583–2021
4, Sovetskaya St., Tver, 170100
References
1. Schwarz K. Ueber penetrierende Magen- und Jeju nalgeschwure. Beitr Klin Chir. 1910; 67: 96–128.
2. Tytgat G. N. Endoscopic transmission of H. pylori. Aliment. Pharmacol. Th er. 1995;9 (2):105–110.
3. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J. P., Kuipers E. J., et al.; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 Jan;66(1):6–30. doi:10.1136/gutjnl-2016–312288
4. Lasebnik L.B., Tkachenko E. I., Abdulganieva D. I., et al. VI National recommendations for the diagnosis and treatment of acid-dependent and Helicobacter pylori- associated diseases (VI Moscow Agreements). Experimental and Clinical Gastroenterology. 2017; 138-(2):3–21. (In Russ.)
5. Ivashkin V.T., Mayev I. V., Tsarkov P. V., et al. Diagnosis and treatment of peptic ulcer disease in adults (Clinical recommendations of the Russian Gastroenterological Association, the Russian Society of Colorectal Surgeons and the Russian Endoscopic Society). Russian Journal of Gastro enterology, Hepatology, Coloproctology. 2020;-30(1):49–70. (In Russ.) doi:10.22416/1382–4376–2020–30–1–49–70
6. Vahrushev Y. M., Busygina M. S., Zelenin V. A. The motor and evacuation function of the stomach and duodenum in patients with ulcer deseas with associated chronic duodenal incuffi ciensy. Experimental and Clinical Gastroenterology. 2018;(9):69–75. (In Russ.) doi:10.31146/1682–8658-ecg-157–9–69–75
7. Trukhmanov A. S., Storonova O. A., Ivashkin V. T. Clinical impact of 24-hour pH-metry in esophageal and stomach diseases diagnostics and pharmacological drugs effi cacy testing. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(6):55–68. (In Russ.) doi: 10.22416/1382–4376–2016–26–6–55–68
8. Mattioli S., et al. Indications for 24-hour gastric pH-monitoring with single and multiple probes in clinical research and practice. Dig. Dis. Sci. 1992; 37 (12): 1793–1801.
9. Kolesnikova I. Yu., Belyaeva G. S., Leontieva V. A., et al. Th e daily rhythms of acid formation and alkalinization in peptic ulcer disease and in healthy individuals. Pathological Physiology and Experimental Th erapy. 2008; 3: 31–33. (In Russ.)
10. Burget D. W., Chiverton S. C., Hunt R. H. Is there an optimal degree of acid supression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990; 99: 345–351.
11. Sheptulin A. A. Th e role of bismuth drugs in elevation of Helicobacter pylori infection eradication effi cacy. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):89–93. (In Russ.) doi:10.22416/1382–4376–2018–28–1–89–93
12. Kononov A. V. Th e Role of the Pathoanatomical Diagno is “Chronic Gastritis” in the System of Personifi ed Cancer Prevention. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(4):91–101. (In Russ.) doi: 10.22416/1382–4376–2018–28–4–91–101
13. Ivashkin V. T., Okhlobystin A. V., Bordin D. S., et al. Postcholecystectomy syndrome: the modern approach: resolution of Advisory council. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;-27(6):96–108. (In Russ.) doi:10.22416/1382–4376–2017–27–6–96–108
Review
For citations:
Kolesnikova I.Yu. Features of duodenogastric refl ux in gastric ulcer. Experimental and Clinical Gastroenterology. 2022;(4):65-70. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-200-4-65-70
Views:
258
Email this article 